PUBLISHER: TechSci Research | PRODUCT CODE: 1255243
PUBLISHER: TechSci Research | PRODUCT CODE: 1255243
Hormonal Contraceptives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Method, By Hormone, By Region, and Competition
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Hormonal Contraceptives Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness regarding the usage of oral contraceptives and their benefits for preventing unintended pregnancy, and population control significantly increased the demand for hormonal contraceptives across different parts of the globe. Additionally, the adoption of hormonal contraceptives has significantly increased, and increasing awareness among women of different age groups for leading a safe life is further expected to increase the demand for different hormonal contraceptive procedures, thereby fuelling the market growth through 2028. For instance, in April 2021, the Food and Drug Administration approved a combination of drospirenone and estetrol tablet Nextstellis marketed by Mayne Pharma for preventing pregnancy, one of the first combination pills containing naturally occurring estrogen. Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in hormonal contraception are further expected to increase the demand for hormonal contraceptives, thereby supporting the market growth. Similarly, supportive initiatives by various governments to increase contraceptive products will propel the growth of the market during the forecast period. For instance, in July 2019, Allergen Plc collaborated with Ashley Tisdale, a musician, and actress, for the awareness campaign "Women Who Know." The World Health Organization provided guidelines, for the usage of hormonal contraceptives, such as intrauterine devices, progestogen injectables, and implants, for women at greater risk of HIV.
Increasing Number of Unplanned Pregnancies
The main factors that affect the growth of the global hormonal contraceptives market are the increasing awareness of family planning due to growing urbanization growing g influence on the changing lifestyle of individuals. Many government organizations are taking initiatives to control the population size. However, hormonal contraceptives are considered more reliable than non-hormonal contraceptives such as condoms and diaphragms, and there is a huge chunk of the female population with unplanned needs. This in turn may help the hormonal contraceptives market grow during the forecast period. As per a publication in PubMed, the number of unintended pregnancies in the U.S. is around three million annually. So, the growing unplanned need for contraceptives significantly increased the demand, which is further boosting the growth of the market in the forecast period. According to NCBI research, only 1 woman out of 1000 women gets pregnant if they take these contraceptives properly.
Development of New Contraceptives
Major companies are innovating to manufacture chewable low-dose oral contraceptives that reduce side effects. The chewable contraceptive initiative was an attempt to reduce side effects while at the same time making it easier for the patients to get into a daily regimen of using this contraceptive. Some of the top companies that develop and sell chewable low-dose oral contraceptives are Lupin pharmaceuticals, Walter Chilcott, and Watson pharmaceuticals. According to the United Nations Contraceptive Use by Method 2019 study, a single method accounts for 50% or more of all contraceptive use in at least one out of every five nations or regions.
Market Segmentation
The global hormonal contraceptive market can be segmented by method, hormone, and region. Based on the method, the market can be segmented into Pills, Intrauterine Devices, Injectables, Vaginal rings, implants, and Others. Based on hormones, the market can be divided into Combination Hormonal Contraceptives v/s Progestin Only. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global hormonal contraceptives market on account of increasing unplanned pregnancies with low-cost product in the country.
Market Players
Abbvie, Inc., Afaxys, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group of Companies, Pfizer Inc., Johnson & Johnson, Lupin Pharmaceuticals Inc., Pregna International Ltd. are some of the leading players operating in the Global Hormonal Contraceptives Market.
Recent Developments
- For instance, in April 2021, Mayne Pharma received U.S. FDA approval for NEXTSTELLIS and estetrol for avoiding pregnancy. It is the only contraceptive pill with E4 and a plant-based estrogen having few important benefits compared to other estrogens.
- For instance, in July 2021, the MHRA launched the OTC sale of contraceptive pills in U.K. pharmacies. Two contraceptive pill brands, Hana and Lovima, are selling desogestrel- synthetic progesterone, OTC, with a brief consultation with a pharmacist.
- For instance, in June 2021, Teva Pharmaceuticals USA launched the generic form of NuvaRing, Ethinyl estradiol, and etonogestrel vaginal ring contraceptive.
- In February 2020, Agile Therapeutics, Inc. received U.S. FDA approval for the Twirla, a transdermal patch containing levonorgestrel and Ethinylestradiol.
Report Scope
In this report, global hormonal contraceptives market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Hormonal Contraceptives Market, By Method:
- Pill
- Intrauterine Device
- Injectable
- Vaginal Ring
- Implant
- Others
Hormonal Contraceptives Market, By Hormone:
- Combination Hormonal Contraceptives
- Progestin Only
Hormonal Contraceptives Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Hormonal Contraceptives Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
- 5.1. Ongoing Clinical Trials
- 5.2. Completed Clinical Trials
- 5.3. Terminated Clinical Trials
- 5.4. Breakdown of Pipeline, By Development Phase
- 5.5. Breakdown of Pipeline, By Status
- 5.6. Breakdown of Pipeline, By Study Type
- 5.7. Breakdown of Pipeline, By Region
- 5.8. Clinical Trials Heat Map
6. Global Hormonal Contraceptives Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Method (Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others)
- 6.2.2. By Hormone (Combination Hormonal Contraceptives v/s Progestin Only)
- 6.2.3. By Region
- 6.2.4. By Company (2022)
- 6.3. Market Map
- 6.3.1. By Method
- 6.3.2. By Hormone
- 6.3.3. By Region
7. North America Hormonal Contraceptives Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Method
- 7.2.2. By Hormone
- 7.2.3. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Hormonal Contraceptives Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Method
- 7.3.1.2.2. By Hormone
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Canada Hormonal Contraceptives Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Method
- 7.3.2.2.2. By Hormone
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Mexico Hormonal Contraceptives Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Method
- 7.3.3.2.2. By Hormone
- 7.3.3.1. Market Size & Forecast
- 7.3.1. United States Hormonal Contraceptives Market Outlook
8. Europe Hormonal Contraceptives Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Method
- 8.2.2. By Hormone
- 8.2.3. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Hormonal Contraceptives Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Method
- 8.3.1.2.2. By Hormone
- 8.3.1.1. Market Size & Forecast
- 8.3.2. Germany Hormonal Contraceptives Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Method
- 8.3.2.2.2. By Hormone
- 8.3.2.1. Market Size & Forecast
- 8.3.3. United Kingdom Hormonal Contraceptives Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Method
- 8.3.3.2.2. By Hormone
- 8.3.3.1. Market Size & Forecast
- 8.3.4. Italy Hormonal Contraceptives Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Method
- 8.3.4.2.2. By Hormone
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Spain Hormonal Contraceptives Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Method
- 8.3.5.2.2. By Hormone
- 8.3.5.1. Market Size & Forecast
- 8.3.1. France Hormonal Contraceptives Market Outlook
9. Asia-Pacific Hormonal Contraceptives Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Method
- 9.2.2. By Hormone
- 9.2.3. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Hormonal Contraceptives Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Method
- 9.3.1.2.2. By Hormone
- 9.3.1.1. Market Size & Forecast
- 9.3.2. India Hormonal Contraceptives Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Method
- 9.3.2.2.2. By Hormone
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Japan Hormonal Contraceptives Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Method
- 9.3.3.2.2. By Hormone
- 9.3.3.1. Market Size & Forecast
- 9.3.4. South Korea Hormonal Contraceptives Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Method
- 9.3.4.2.2. By Hormone
- 9.3.4.1. Market Size & Forecast
- 9.3.5. Australia Hormonal Contraceptives Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Method
- 9.3.5.2.2. By Hormone
- 9.3.5.1. Market Size & Forecast
- 9.3.1. China Hormonal Contraceptives Market Outlook
10. South America Hormonal Contraceptives Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Method
- 10.2.2. By Hormone
- 10.2.3. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Hormonal Contraceptives Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Method
- 10.3.1.2.2. By Hormone
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Argentina Hormonal Contraceptives Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Method
- 10.3.2.2.2. By Hormone
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Colombia Hormonal Contraceptives Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Method
- 10.3.3.2.2. By Hormone
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Hormonal Contraceptives Market Outlook
11. Middle East and Africa Hormonal Contraceptives Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Method
- 11.2.2. By Hormone
- 11.2.3. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Hormonal Contraceptives Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Method
- 11.3.1.2.2. By Hormone
- 11.3.1.1. Market Size & Forecast
- 11.3.2. Saudi Arabia Hormonal Contraceptives Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Method
- 11.3.2.2.2. By Hormone
- 11.3.2.1. Market Size & Forecast
- 11.3.3. UAE Hormonal Contraceptives Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Method
- 11.3.3.2.2. By Hormone
- 11.3.3.1. Market Size & Forecast
- 11.3.4. Turkey Hormonal Contraceptives Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Method
- 11.3.4.2.2. By Hormone
- 11.3.4.1. Market Size & Forecast
- 11.3.5. Egypt Hormonal Contraceptives Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Method
- 11.3.5.2.2. By Hormone
- 11.3.5.1. Market Size & Forecast
- 11.3.1. South Africa Hormonal Contraceptives Market Outlook
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
- 13.1. Recent Developments
- 13.2. Mergers & Acquisitions
- 13.3. Product Launches
14. Competitive Landscape
- 14.1. Business Overview
- 14.2. Product Offerings
- 14.3. Recent Developments
- 14.4. Financials (As Reported)
- 14.5. Key Personnel
- 14.6. SWOT Analysis
- 14.6.1. Abbvie, Inc.
- 14.6.2. Afaxys, Inc.
- 14.6.3. Teva Pharmaceuticals Industries Ltd.
- 14.6.4. Bayer AG
- 14.6.5. Merck & Co. Inc.
- 14.6.6. Organon Group of Companies
- 14.6.7. Pfizer Inc.
- 14.6.8. Johnson & Johnson
- 14.6.9. Lupin Pharmaceuticals Inc.
- 14.6.10. Pregna International Ltd.
15. Strategic Recommendations
